Nanoengineered Antibacterial Coatings and Materials: A Perspective
Source abstract
Abstract
This feature article begins by outlining the problem of infection and its implication on healthcare. The initial introductory section is followed by a description of the four distinct classes of antibacterial coatings and materials, i.e., bacteria repealing, contact killing, releasing and responsive, that were developed over the years by our team and others. Specific examples of each individual class of antibacterial materials and a discussion on the pros and cons of each strategy are provided. The article contains a dedicated section focused on silver nanoparticle based coatings and materials, which have attracted tremendous interest from the scientific and medical communities. The article concludes with the author’s view regarding the future of the field.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Engineering, The University of South Australia, Mawson Lakes SA 5095, Australia
Funding
Alexander von Humboldt-Stiftung · National Health and Medical Research Council · Australian Research Council
References (93)
Show source-provided references
1. The significance of infection related to orthopedic devices and issues of antibiotic resistance10.1016/j.biomaterials.2005.11.044 ↗
2. Antibacterial surfaces for biomedical devices10.1586/erd.09.36 ↗
3. The epidemiology of revision total knee arthroplasty in the United States10.1016/j.arth.2008.11.063 ↗
4. Economic burden of periprosthetic joint infection in the United States10.1016/j.arth.2012.02.022 ↗
5. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia10.2215/CJN.00290107 ↗
6. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand10.1053/j.ajkd.2008.06.032 ↗
7. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit10.1001/archsurg.136.2.229 ↗
8. Current concepts—Treatment of infections associated with surgical implants10.1056/NEJMra035415 ↗
9. Preventing implant-associated infections by silver coating10.1128/AAC.02934-15 ↗
10. Current concepts: Prosthetic-joint infections10.1056/NEJMra040181 ↗
11. Antibacterial surfaces and coatings produced by plasma techniques10.1002/ppap.201100097 ↗
12. Responsive and “smart” antibacterial surfaces: Common approaches and new developments (Review)10.1116/1.4866697 ↗
13. Silver as antibacterial agent: Ion, nanoparticle, and metal10.1002/anie.201205923 ↗
14. Antibiofouling properties of plasma-deposited Oxazoline-based thin films10.1021/acsami.6b00330 ↗
15. Plasma polymerised polyoxazoline thin films for biomedical applications10.1039/C5CC00260E ↗
16. Effects of precursor and deposition conditions on prevention of bacterial biofilm growth on Chlorinated plasma polymers10.1002/ppap.201500191 ↗
17. Plasma polymerization of 1,1,1-trichloroethane yields a coating with robust antibacterial surface properties10.1039/C4RA01892C ↗
18. Plasma polymerization of TEMPO yields coatings containing stable Nitroxide radicals for controlling interactions with Prokaryotic and Eukaryotic Cells10.1021/acsanm.8b01314 ↗
19. Influence of immobilized quaternary ammonium group surface density on antimicrobial efficacy and cytotoxicity10.1080/08927014.2015.1115977 ↗
20. Substrate independent approach for immobilisation of quaternary ammonium compounds to surfaces to reduce bio-burden10.4028/www.scientific.net/MSF.783-786.1389 ↗
21. Controlled release of levofloxacin sandwiched between two plasma polymerized layers on a solid carrier10.1021/am201320a ↗
22. Controlled and sustained release of pharmaceuticals via single step solvent-free encapsulation10.1039/C4CC08151J ↗
23. Nitric oxide releasing plasma polymer coating with bacteriostatic properties and no cytotoxic side effects10.1039/C5CC01722J ↗
24. Nitric oxide-releasing porous silicon nanoparticles10.1186/1556-276X-9-333 ↗
25. Antibacterial properties of nitric oxide-releasing porous silicon nanoparticles10.1039/C5TB02551F ↗
26. RAFT-derived antimicrobial polymethacrylates: Elucidating the impact of end-groups on activity and cytotoxicity10.1039/C4PY00652F ↗
27. Guanylated polymethacrylates: A class of potent antimicrobial polymers with low hemolytic activity10.1021/bm401128r ↗
28. Antimicrobial polymethacrylates synthesized as mimics of tryptophan-rich cationic peptides10.1021/mz5001527 ↗
29. Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection10.1021/bm302003m ↗
30. Enzymatic degradation of poly(L-lactide) nanoparticles followed by the release of octenidine and their bactericidal effects10.1016/j.nano.2013.07.002 ↗
31. Nanoengineered plasma polymer films for biomaterial applications10.1007/s11090-013-9506-0 ↗
32. Surface chemical gradient affects the differentiation of human adipose-derived stem cells via ERK1/2 signaling pathway10.1021/acsami.5b04635 ↗
33. PH-tunable gradients of wettability and surface potential10.1039/c2sm25221j ↗
34. A mechanistic study of the plasma polymerization of ethanol10.1002/ppap.201300110 ↗
35. Reactive epoxy-functionalized thin films by a pulsed plasma polymerization process10.1021/la801140u ↗
36. Secrets of plasma-deposited polyoxazoline functionality lie in the plasma phase10.1021/acs.chemmater.7b03023 ↗
37. Laboratory scale systems for the plasma treatment and coating of particles10.1002/ppap.201400141 ↗
38. Role of positive ions in determining the deposition rate and film chemistry of continuous wave hexamethyl disiloxane plasmas10.1021/la202010n ↗
39. Immobilized streptavidin gradients as bioconjugation platforms10.1021/la204714p ↗
40. A substrate independent approach for generation of surface gradients10.1016/j.tsf.2012.04.087 ↗
41. Functionality of proteins bound to plasma polymer surfaces10.1021/am300128n ↗
42. Early stages of growth of plasma polymer coatings deposited from nitrogen- and oxygen-containing monomers10.1002/ppap.201000030 ↗
43. Substrate influence on the initial growth phase of plasma-deposited polymer films10.1039/b904367e ↗
44. Surface morphology in the early stages of plasma polymer film growth from amine-containing monomers10.1002/ppap.201000140 ↗
45. Functional polymers as nanoscopic building blocks10.1016/S0928-4931(02)00256-4 ↗
46. “Thunderstruck”: Plasma-Polymer-Coated Porous Silicon Microparticles As a Controlled Drug Delivery System10.1021/acsami.5b12433 ↗
47. Plasma polymer facilitated magnetic technology for removal of oils from contaminated waters10.1016/j.envpol.2018.05.023 ↗
48. A novel technology for the rapid, selective, magnetic removal of pathogenesis-related proteins from wines10.1016/j.foodchem.2017.04.050 ↗
49. Tuning and predicting the wetting of nanoengineered material surface10.1039/C5NR08329J ↗
50. The Role of Surface Nanotopography and Chemistry on Primary Neutrophil and Macrophage Cellular Responses10.1002/adhm.201500845 ↗
51. Properties and reactivity of polyoxazoline plasma polymer films10.1039/C5TB00901D ↗
52. Preserving the reactivity of coatings plasma deposited from oxazoline precursors—An in depth study10.1002/ppap.201800130 ↗
53. Macgregor, M., and Vasilev, K. (2019). Perspective on plasma polymers for applied biomaterials nanoengineering and the recent rise of oxazolines. Materials, 12.10.3390/ma12010191 ↗
54. Plasma derived oxazoline based coatings for advanced medical technologies
55. Protein Interactions with Nanoengineered Polyoxazoline Surfaces Generated via Plasma Deposition10.1021/acs.langmuir.7b01279 ↗
56. Plasma deposited poly-oxazoline nanotextured surfaces dictate osteoimmunomodulation towards ameliorative osteogenesis10.1016/j.actbio.2019.06.058 ↗
57. A platform for selective immuno-capture of cancer cells from urine10.1016/j.bios.2017.02.011 ↗
58. Creating Nano-engineered Biomaterials with Well-Defined Surface Descriptors10.1021/acsanm.8b00458 ↗
59. Visalakshan, R.M., MacGregor, M.N., Sasidharan, S., Ghazaryan, A., Mierczynska-Vasilev, A.M., Morsbach, S., Mailänder, V., Landfester, K., Hayball, J.D., and Vasilev, K. (2019). Biomaterial Surface Hydrophobicity-Mediated Serum Protein Adsorption and Immune Responses. ACS Appl. Mater. Interfaces.10.1021/acsami.9b09900 ↗
60. Al-Bataineh, S.A., Cavallaro, A.A., Michelmore, A., Macgregor, M.N., Whittle, J.D., and Vasilev, K. (2019). Deposition of 2-oxazoline-based plasma polymer coatings using atmospheric pressure helium plasma jet. Plasma Process. Polym.10.1002/ppap.201900104 ↗
61. Bactericidal activity of black silicon10.1038/ncomms3838 ↗
62. Bactericidal effects of plasma-modified surface chemistry of silicon nanograss10.1088/0022-3727/49/30/304001 ↗
63. History of the medical use of silver10.1089/sur.2008.9941 ↗
64. Antibacterial surfaces by adsorptive binding of polyvinyl-sulphonate-stabilized silver nanoparticles10.1088/0957-4484/21/21/215102 ↗
65. Antibacterial properties of silver-loaded plasma polymer coatings10.1155/2012/674145 ↗
66. Transformation of four silver/silver chloride nanoparticles during anaerobic treatment of wastewater and post-processing of sewage sludge10.1016/j.envpol.2013.01.029 ↗
67. Poulter, N., Vasilev, K., Griesser, S.S., and Griesser, H.J. (2013). Silver containing biomaterials. Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies, Springer.10.1007/978-1-4614-1031-7_14 ↗
68. Synthesis and surface immobilization of antibacterial hybrid silver-poly(L-lactide) nanoparticles10.1088/0957-4484/25/30/305102 ↗
69. Synthesis and antibacterial properties of a hybrid of silver-potato starch nanocapsules by miniemulsion/polyaddition polymerization10.1039/c3tb21690j ↗
70. Antibacterial efficacy and cytotoxicity of silver-nanoparticle–based coatings facilitated by a plasma deposited polymer interlayer10.1615/PlasmaMed.2014011974 ↗
71. Substrate independent silver nanoparticle based antibacterial coatings10.1016/j.biomaterials.2014.02.033 ↗
72. Fate of zinc and silver engineered nanoparticles in sewerage networks10.1016/j.watres.2015.03.003 ↗
73. In situ chemical transformations of silver nanoparticles along the water-sediment continuum10.1021/es504395m ↗
74. Quantifying the adsorption of ionic silver and functionalized nanoparticles during ecotoxicity testing: Test container effects and recommendations10.3109/17435390.2014.994570 ↗
75. Antibacterial Plasma Polymer Films Conjugated with Phospholipid Encapsulated Silver Nanoparticles10.1021/acsbiomaterials.5b00338 ↗
76. Silver nanoparticles: Synthesis, antimicrobial coatings, and applications for medical devices10.2174/1874464808666150331222126 ↗
77. Antibacterial properties of silver dendrite decorated silicon nanowires10.1039/C6RA13734B ↗
78. ‘Chocolate’ silver nanoparticles: Synthesis, antibacterial activity and cytotoxicity10.1016/j.jcis.2016.08.003 ↗
79. Silver nanoparticle based coatings enhance adipogenesis compared to osteogenesis in human mesenchymal stem cells through oxidative stress10.1039/C5TB02482J ↗
80. A comparative assessment of nanoparticulate and metallic silver coated dressings10.2174/1874464809666160127230508 ↗
81. Synergic bactericidal effects of reduced graphene oxide and silver nanoparticles against Gram-positive and Gram-negative bacteria10.1038/s41598-017-01669-5 ↗
82. Silver-coated megaprostheses: Review of the literature10.1007/s00590-017-1933-9 ↗
83. Silver nanoparticle modified surfaces induce differentiation of mouse kidney-derived stem cells10.1039/C8RA02145G ↗
84. Self-sterilizing antibacterial silver-loaded microneedles10.1039/C8CC06035E ↗
85. Tunable antibacterial coatings that support mammalian cell growth10.1021/nl903274q ↗
86. Chowdhury, N.R., Cowin, A.J., Zilm, P., and Vasilev, K. (2018). “Chocolate” gold nanoparticles—One pot synthesis and biocompatibility. Nanomaterials, 8.10.3390/nano8070496 ↗
87. Binding of Nanoparticles to Aminated Plasma Polymer Surfaces is Controlled by Primary Amine Density and Solution pH10.1021/acs.jpcc.8b03382 ↗
88. Biocompatible functionalisation of nanoclays for improved environmental remediation10.1039/C8CS01019F ↗
89. Core-in-cage structure regulated properties of ultra-small gold nanoparticles
90. Ravindran Girija, A., Balasubramanian, S., Bright, R., Cowin, A.J., Goswami, N., and Vasilev, K. (2019). Ultrasmall Gold Nanocluster Based Antibacterial Nanoaggregates for Infectious Wound Healing. ChemNanoMat.10.1002/cnma.201900366 ↗
91. Controlled drug release from porous materials by plasma polymer deposition10.1039/b919840g ↗
92. Controlled release and bioactivity of the monoclonal antibody rituximab from a porous matrix: A potential in situ therapeutic device10.1016/j.matlet.2014.05.110 ↗
93. Temperature-Controlled Antimicrobial Release from Poly(diethylene glycol methylether methacrylate)-Functionalized Bottleneck-Structured Porous Silicon for the Inhibition of Bacterial Growth10.1002/macp.201600099 ↗